Friday, July 10, 2026

pharma · Female Infertility · Breast Feeding

Abbott Pathology

Abbott Australasia Pty is a pharma organization headquartered in ROME, AU. Primary therapeutic focus areas include Female Infertility, Breast Feeding, Children, Sarcoma, Kaposi, Diabetic Nephropathy. NovaPharmaNews links

Mile End, AU HQ
2001 Founded
41 Employees
TGA registrant Type
Company details
Status
Public
HQ
Mile End, AU
Founded
2001
Employees
41
Programs
6
Drugs
9
Patents
0
Clinical program

Zemplar (paricalcitol ) capsules

Phase 2 · small molecule · Diabetic Nephropathy

Zemplar (paricalcitol ) capsules for Diabetic Nephropathy is a Phase 2 program (small_molecule) at Abbott Australasia Pty Ltd with 1 ClinicalTrials.gov record(s).

← All Abbott Australasia Pty Ltd projects Phase 2 small molecule completed

Internal code M05-741

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Abbott Australasia Pty Ltd
Phase
Phase 2
Modality
small_molecule
Indication
Diabetic Nephropathy
Status
completed
Trials
1